CL SEC filings (2026)
CIK 21665 · Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844) · incorporated in DE · fiscal year ends in December
3,941 filings on EDGAR since 1994 · 34 annual, 99 quarterly, 226 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
August 2026
- Aug 24Insider saleTsourapas Panagiotis (COO, CD, EMEA, APac, Skin) sold 10,000 shares for $920K at $92.05
- Aug 6Insider saleCAHILL JOHN T (Director) sold 4,170 shares for $389K at $93.37
- Aug 5Insider saleWallace Noel R. (Chairman, President & CEO · Director) sold 161,021 shares for $14.9M at $92.52
- Aug 4Insider saleWallace Noel R. (Chairman, President & CEO · Director) sold 161,021 shares for $14.8M at $91.92
July 2026
May 2026
- May 15Insider saleMalcolm Gregory (EVP and Controller) sold 2,300 shares for $203K at $88.44
- May 138-K8-K · Shareholder vote results
- May 7Insider saleMassey Sally (Chief People Officer) sold 8,599 shares for $752K at $87.41
- May 1EarningsEarnings release — EPS $0.97 vs $0.95 est. (+2.1%); revenue $5.32B (+8% y/y) 2.2%
- May 1ReportQuarterly report, Q1 2026 — revenue $5.32B (+8% y/y), net income $646.0M, EPS $0.80
April 2026
- Apr 16ProxyProxy · Additional proxy materials
- Apr 98-K8-K · Directors or officers; compensation
March 2026
- Mar 25ProxyProxy · Annual report to shareholders
- Mar 25ProxyProxy · Additional proxy materials
- Mar 25ProxyProxy · Proxy statement
- Mar 178-K8-K · Other events
- Mar 128-K8-K · Directors or officers; compensation
February 2026
- Feb 23ReportAnnual report, FY2025 — revenue $20.38B (+1% y/y), net income $2.13B, EPS $2.63
- Feb 12Insider saleTsourapas Panagiotis (COO, Eur., APac, Afr Eur, Skin) sold 15,000 shares for $1.5M at $97.81
- Feb 11Insider saleTsourapas Panagiotis (COO, Eur., APac, Afr Eur, Skin) sold 35,000 shares for $3.3M at $94.61
- Feb 10Insider saleHazlin John (Chief Growth Officer) sold 20,989 shares for $2.0M at $94.25
- Feb 6Insider saleMalcolm Gregory (EVP and Controller) sold 12,747 shares for $1.2M at $94.91
- Feb 5Insider saleMassey Sally (Chief Human Resources Officer) sold 15,851 shares for $1.5M at $95.03
- Feb 4Insider saleSUTULA STANLEY J III (Chief Financial Officer) sold 97,843 shares for $9.2M at $94.27
- Feb 4Insider saleWallace Noel R. (Chairman, President & CEO · Director) sold 45,568 shares for $4.3M at $93.91
- Feb 4Insider saleDaniels Jennifer (CLO and Secretary) sold 22,000 shares for $2.1M at $94.34
January 2026
- Jan 30EarningsEarnings release — EPS $0.91 vs $0.91 est. (+4.4%); revenue $5.23B (+6% y/y) 5.9%
November 2025
- Nov 108-K8-K · Other events
October 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $57.0M in 14 sales and bought nothing on the open market; 103 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Aug 24, 2026Form 4 | Tsourapas PanagiotisCOO, CD, EMEA, APac, SkinSold · $920K · 10,000 sh |
| Aug 6, 2026Form 4 | CAHILL JOHN TDirectorSold · $389K · 4,170 sh |
| Aug 5, 2026Form 4 | Wallace Noel R.Chairman, President & CEO · DirectorSold · $14.9M · 161,021 sh |
| Aug 4, 2026Form 4 | Wallace Noel R.Chairman, President & CEO · DirectorSold · $14.8M · 161,021 sh |
| May 15, 2026Form 4 | Malcolm GregoryEVP and ControllerSold · $203K · 2,300 sh |
| May 7, 2026Form 4 | Massey SallyChief People OfficerSold · $752K · 8,599 sh |
| Feb 12, 2026Form 4 | Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, SkinSold · $1.5M · 15,000 sh |
| Feb 11, 2026Form 4 | Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, SkinSold · $3.3M · 35,000 sh |
| Feb 10, 2026Form 4 | Hazlin JohnChief Growth OfficerSold · $2.0M · 20,989 sh |
| Feb 6, 2026Form 4 | Malcolm GregoryEVP and ControllerSold · $1.2M · 12,747 sh |
| Feb 5, 2026Form 4 | Massey SallyChief Human Resources OfficerSold · $1.5M · 15,851 sh |
| Feb 4, 2026Form 4 | SUTULA STANLEY J IIIChief Financial OfficerSold · $9.2M · 97,843 sh |
| Feb 4, 2026Form 4 | Wallace Noel R.Chairman, President & CEO · DirectorSold · $4.3M · 45,568 sh |
| Feb 4, 2026Form 4 | Daniels JenniferCLO and SecretarySold · $2.1M · 22,000 sh |
Awards, exercises, withholding and plan purchases · 103 transactions
| Date | Insider |
|---|---|
| Oct 1, 2026Form 4 | NORRINGTON LORRIE MDirectorAward · $26K · 300 sh |
| Oct 1, 2026Form 4 | BILBREY JOHN PDirectorAward · $24K · 271 sh |
| Oct 1, 2026Form 4 | Newman BrianDirectorAward · $19K · 214 sh |
| Sep 16, 2026Form 4 | Wallace Noel R.Chairman, President & CEO · DirectorAward · Stock Option (Right to Buy) · $0 · 205,197 sh |
| Sep 16, 2026Form 4 | SUTULA STANLEY J IIIChief Financial OfficerAward · Stock Option (Right to Buy) · $0 · 55,674 sh |
| Sep 16, 2026Form 4 | GRANT SHANECOO, AmericasAward · Stock Option (Right to Buy) · $0 · 50,902 sh |
| Sep 16, 2026Form 4 | Tsourapas PanagiotisCOO, CD, EMEA, APac, SkinAward · Stock Option (Right to Buy) · $0 · 31,814 sh |
| Sep 16, 2026Form 4 | Wallace Noel R.Chairman, President & CEO · DirectorAward · $0 · 29,649 sh |
| Sep 16, 2026Form 4 | Hazlin JohnChief Growth OfficerAward · Stock Option (Right to Buy) · $0 · 27,042 sh |
| Sep 16, 2026Form 4 | Massey SallyChief People OfficerAward · Stock Option (Right to Buy) · $0 · 23,065 sh |
| Sep 16, 2026Form 4 | Fishbone BetsyCLO and SecretaryAward · Stock Option (Right to Buy) · $0 · 15,271 sh |
| Sep 16, 2026Form 4 | SUTULA STANLEY J IIIChief Financial OfficerAward · $0 · 8,045 sh |
| Sep 16, 2026Form 4 | Malcolm GregoryEVP and ControllerAward · Stock Option (Right to Buy) · $0 · 7,477 sh |
| Sep 16, 2026Form 4 | GRANT SHANECOO, AmericasAward · $0 · 7,355 sh |
| Sep 16, 2026Form 4 | Tsourapas PanagiotisCOO, CD, EMEA, APac, SkinAward · $0 · 4,597 sh |
| Sep 16, 2026Form 4 | Hazlin JohnChief Growth OfficerAward · $0 · 3,908 sh |
| Sep 16, 2026Form 4 | Massey SallyChief People OfficerAward · $0 · 3,333 sh |
| Sep 16, 2026Form 4 | Fishbone BetsyCLO and SecretaryAward · $0 · 2,207 sh |
| Sep 16, 2026Form 4 | Malcolm GregoryEVP and ControllerAward · $0 · 1,081 sh |
| Sep 13, 2026Form 4 | Wallace Noel R.Chairman, President & CEO · DirectorTax withholding · $425K · 4,892 sh |
| Sep 13, 2026Form 4 | SUTULA STANLEY J IIIChief Financial OfficerTax withholding · $120K · 1,385 sh |
| Sep 13, 2026Form 4 | Tsourapas PanagiotisCOO, CD, EMEA, APac, SkinTax withholding · $80K · 922 sh |
| Sep 13, 2026Form 4 | Massey SallyChief People OfficerTax withholding · $60K · 686 sh |
| Sep 13, 2026Form 4 | Hazlin JohnChief Growth OfficerTax withholding · $43K · 499 sh |
| Sep 13, 2026Form 4 | Fishbone BetsyCLO and SecretaryTax withholding · $41K · 472 sh |
| Sep 13, 2026Form 4 | Malcolm GregoryEVP and ControllerTax withholding · $20K · 225 sh |
| Sep 12, 2026Form 4 | Wallace Noel R.Chairman, President & CEO · DirectorTax withholding · $305K · 3,516 sh |
| Sep 12, 2026Form 4 | SUTULA STANLEY J IIIChief Financial OfficerTax withholding · $80K · 927 sh |
| Sep 12, 2026Form 4 | Tsourapas PanagiotisCOO, CD, EMEA, APac, SkinTax withholding · $54K · 618 sh |
| Sep 12, 2026Form 4 | Massey SallyChief People OfficerTax withholding · $40K · 459 sh |
| Sep 12, 2026Form 4 | Hazlin JohnChief Growth OfficerTax withholding · $38K · 439 sh |
| Sep 12, 2026Form 4 | Fishbone BetsyCLO and SecretaryTax withholding · $29K · 331 sh |
| Sep 12, 2026Form 4 | Malcolm GregoryEVP and ControllerTax withholding · $13K · 151 sh |
| Sep 11, 2026Form 4 | Wallace Noel R.Chairman, President & CEO · DirectorTax withholding · $353K · 4,071 sh |
| Sep 11, 2026Form 4 | SUTULA STANLEY J IIIChief Financial OfficerTax withholding · $104K · 1,197 sh |
| Sep 11, 2026Form 4 | Tsourapas PanagiotisCOO, CD, EMEA, APac, SkinTax withholding · $59K · 684 sh |
| Sep 11, 2026Form 4 | Massey SallyChief People OfficerTax withholding · $57K · 651 sh |
| Sep 11, 2026Form 4 | Hazlin JohnChief Growth OfficerTax withholding · $56K · 649 sh |
| Sep 11, 2026Form 4 | GRANT SHANECOO, AmericasTax withholding · $54K · 622 sh |
| Sep 11, 2026Form 4 | Fishbone BetsyCLO and SecretaryTax withholding · $35K · 404 sh |
| Sep 11, 2026Form 4 | Malcolm GregoryEVP and ControllerTax withholding · $14K · 167 sh |
| Aug 6, 2026Form 4 | CAHILL JOHN TDirectorExercise or conversion · $298K · 4,170 sh |
| Aug 6, 2026Form 4 | CAHILL JOHN TDirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 4,170 sh |
| Aug 5, 2026Form 4 | Wallace Noel R.Chairman, President & CEO · DirectorExercise or conversion · $11.6M · 161,021 sh |
| Aug 5, 2026Form 4 | Wallace Noel R.Chairman, President & CEO · DirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 161,021 sh |
| Aug 4, 2026Form 4 | Wallace Noel R.Chairman, President & CEO · DirectorExercise or conversion · $11.6M · 161,021 sh |
| Aug 4, 2026Form 4 | Wallace Noel R.Chairman, President & CEO · DirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 161,021 sh |
| Jul 1, 2026Form 4 | NORRINGTON LORRIE MDirectorAward · $26K · 293 sh |
| Jul 1, 2026Form 4 | BILBREY JOHN PDirectorAward · $24K · 265 sh |
| Jul 1, 2026Form 4 | Newman BrianDirectorAward · $19K · 209 sh |
| Jun 16, 2026Form 4 | GRANT SHANECOO, AmericasTax withholding · $2.1M · 23,347 sh |
| May 11, 2026Form 4 | BILBREY JOHN PDirectorAward · Stock Option (Right to Buy) · $0 · 2,424 sh |
| May 11, 2026Form 4 | CAHILL JOHN TDirectorAward · Stock Option (Right to Buy) · $0 · 2,424 sh |
| May 11, 2026Form 4 | Edwards LisaDirectorAward · Stock Option (Right to Buy) · $0 · 2,424 sh |
| May 11, 2026Form 4 | HARRIS C MARTINDirectorAward · Stock Option (Right to Buy) · $0 · 2,424 sh |
| May 11, 2026Form 4 | HUNDMEJEAN MARTINADirectorAward · Stock Option (Right to Buy) · $0 · 2,424 sh |
| May 11, 2026Form 4 | Nelson Kimberly ADirectorAward · Stock Option (Right to Buy) · $0 · 2,424 sh |
| May 11, 2026Form 4 | Newman BrianDirectorAward · Stock Option (Right to Buy) · $0 · 2,424 sh |
| May 11, 2026Form 4 | NORRINGTON LORRIE MDirectorAward · Stock Option (Right to Buy) · $0 · 2,424 sh |
| May 11, 2026Form 4 | BILBREY JOHN PDirectorAward · $0 · 2,075 sh |
| May 11, 2026Form 4 | CAHILL JOHN TDirectorAward · $0 · 2,075 sh |
| May 11, 2026Form 4 | Edwards LisaDirectorAward · $0 · 2,075 sh |
| May 11, 2026Form 4 | HUNDMEJEAN MARTINADirectorAward · $0 · 2,075 sh |
| May 11, 2026Form 4 | Nelson Kimberly ADirectorAward · $0 · 2,075 sh |
| May 11, 2026Form 4 | Newman BrianDirectorAward · $0 · 2,075 sh |
| May 11, 2026Form 4 | NORRINGTON LORRIE MDirectorAward · $0 · 2,075 sh |
| May 11, 2026Form 4 | BOERNER CHRISTOPHER S.DirectorAward · Stock Option (Right to Buy) · $0 · 2,020 sh |
| May 11, 2026Form 4 | HARRIS C MARTINDirectorAward · $0 · 1,556 sh |
| May 11, 2026Form 4 | BOERNER CHRISTOPHER S.DirectorAward · $0 · 1,383 sh |
| Apr 1, 2026Form 4 | NORRINGTON LORRIE MDirectorAward · $26K · 294 sh |
| Apr 1, 2026Form 4 | BILBREY JOHN PDirectorAward · $24K · 266 sh |
| Apr 1, 2026Form 4 | Newman BrianDirectorAward · $19K · 210 sh |
| Feb 23, 2026Form 4 | Wallace Noel R.Chairman, President & CEO · DirectorTax withholding · $6.6M · 68,252 sh |
| Feb 23, 2026Form 4 | SUTULA STANLEY J IIIChief Financial OfficerTax withholding · $1.9M · 19,746 sh |
| Feb 23, 2026Form 4 | Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, SkinTax withholding · $1.3M · 13,081 sh |
| Feb 23, 2026Form 4 | Daniels JenniferCLO and SecretaryTax withholding · $1.2M · 12,351 sh |
| Feb 23, 2026Form 4 | Massey SallyChief Human Resources OfficerTax withholding · $797K · 8,206 sh |
| Feb 23, 2026Form 4 | Hazlin JohnChief Growth OfficerTax withholding · $594K · 6,117 sh |
| Feb 23, 2026Form 4 | Malcolm GregoryEVP and ControllerTax withholding · $219K · 2,260 sh |
| Feb 23, 2026Form 4 | Wallace Noel R.Chairman, President & CEO · DirectorAward · $0 · 136,710 sh |
| Feb 23, 2026Form 4 | SUTULA STANLEY J IIIChief Financial OfficerAward · $0 · 38,678 sh |
| Feb 23, 2026Form 4 | Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, SkinAward · $0 · 25,742 sh |
| Feb 23, 2026Form 4 | Daniels JenniferCLO and SecretaryAward · $0 · 25,742 sh |
| Feb 23, 2026Form 4 | Massey SallyChief Human Resources OfficerAward · $0 · 16,805 sh |
| Feb 23, 2026Form 4 | Hazlin JohnChief Growth OfficerAward · $0 · 12,803 sh |
| Feb 23, 2026Form 4 | Malcolm GregoryEVP and ControllerAward · $0 · 6,268 sh |
| Feb 12, 2026Form 4 | Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, SkinExercise or conversion · $1.1M · 15,000 sh |
| Feb 12, 2026Form 4 | Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, SkinExercise or conversion · Stock Option (Right to Buy) · $0 · 15,000 sh |
| Feb 11, 2026Form 4 | Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, SkinExercise or conversion · $2.7M · 35,000 sh |
| Feb 11, 2026Form 4 | Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, SkinExercise or conversion · Stock Option (Right to Buy) · $0 · 35,000 sh |
| Feb 10, 2026Form 4 | Hazlin JohnChief Growth OfficerExercise or conversion · $1.6M · 20,989 sh |
| Feb 10, 2026Form 4 | Hazlin JohnChief Growth OfficerExercise or conversion · Stock Option (Right to Buy) · $0 · 20,989 sh |
| Feb 6, 2026Form 4 | Malcolm GregoryEVP and ControllerExercise or conversion · $974K · 12,747 sh |
| Feb 6, 2026Form 4 | Malcolm GregoryEVP and ControllerExercise or conversion · Stock Option (Right to Buy) · $0 · 12,747 sh |
| Feb 5, 2026Form 4 | Massey SallyChief Human Resources OfficerExercise or conversion · $1.2M · 15,851 sh |
| Feb 5, 2026Form 4 | Massey SallyChief Human Resources OfficerExercise or conversion · Stock Option (Right to Buy) · $0 · 15,851 sh |
| Feb 4, 2026Form 4 | SUTULA STANLEY J IIIChief Financial OfficerExercise or conversion · $8.0M · 97,843 sh |
| Feb 4, 2026Form 4 | Daniels JenniferCLO and SecretaryExercise or conversion · $1.6M · 22,000 sh |
| Feb 4, 2026Form 4 | SUTULA STANLEY J IIIChief Financial OfficerExercise or conversion · Stock Option (Right to Buy) · $0 · 97,843 sh |
| Feb 4, 2026Form 4 | Daniels JenniferCLO and SecretaryExercise or conversion · Stock Option (Right to Buy) · $0 · 22,000 sh |
| Jan 2, 2026Form 4 | NORRINGTON LORRIE MDirectorAward · $26K · 333 sh |
| Jan 2, 2026Form 4 | BILBREY JOHN PDirectorAward · $24K · 301 sh |
| Jan 2, 2026Form 4 | Newman BrianDirectorAward · $19K · 238 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 14 filings
| Filed | What it is |
|---|---|
| Jul 31, 202610-Q | Quarterly report, Q2 2026 — revenue $5.36B (+5% y/y), net income $693.0M, EPS $0.86 |
| Jul 31, 20268-K | Earnings release — EPS $0.99 vs $0.95 est. (+4.2%); revenue $5.36B (+5% y/y) 0.3% |
| May 13, 20268-K | Shareholder vote results |
| May 1, 202610-Q | Quarterly report, Q1 2026 — revenue $5.32B (+8% y/y), net income $646.0M, EPS $0.80 |
| May 1, 20268-K | Earnings release — EPS $0.97 vs $0.95 est. (+2.1%); revenue $5.32B (+8% y/y) 2.2% |
| Apr 16, 2026DEFA14A | Additional proxy materials |
| Apr 9, 20268-K | Directors or officers; compensation |
| Mar 25, 2026ARS | Annual report to shareholders |
| Mar 25, 2026DEFA14A | Additional proxy materials |
| Mar 25, 2026DEF 14A | Proxy statement |
| Mar 17, 20268-K | Other events |
| Mar 12, 20268-K | Directors or officers; compensation |
| Feb 23, 202610-K | Annual report, FY2025 — revenue $20.38B (+1% y/y), net income $2.13B, EPS $2.63 |
| Jan 30, 20268-K | Earnings release — EPS $0.91 vs $0.91 est. (+4.4%); revenue $5.23B (+6% y/y) 5.9% |
2025 · 18 filings
| Filed | What it is |
|---|---|
| Nov 10, 20258-K | Other events |
| Oct 31, 202510-Q | Quarterly report, Q3 2025 — revenue $5.13B (+2% y/y), net income $735.0M, EPS $0.91 |
| Oct 31, 20258-K | Earnings release — EPS $0.91 vs $0.89 est. (+2.3%); revenue $5.13B (+2% y/y) 0.7% |
| Aug 1, 202510-Q | Quarterly report, Q2 2025 — revenue $5.11B (+1% y/y), net income $743.0M, EPS $0.91 |
| Aug 1, 20258-K | Earnings release — EPS $0.92 vs $0.89 est. (+3.4%); revenue $5.11B (+1% y/y) 0.4% |
| May 29, 20258-K | Directors or officers; compensation |
| May 14, 20258-K | Shareholder vote results |
| May 2, 20258-K | Other events |
| Apr 25, 202510-Q | Quarterly report, Q1 2025 — revenue $4.91B (−3% y/y), net income $690.0M, EPS $0.85 |
| Apr 25, 20258-K | Earnings release — EPS $0.91 vs $0.86 est. (+5.8%); revenue $4.91B (−3% y/y) 1.3% |
| Apr 24, 2025PX14A6G | Shareholder exempt solicitation |
| Apr 17, 2025DEFA14A | Additional proxy materials |
| Mar 26, 2025ARS | Annual report to shareholders |
| Mar 26, 2025DEFA14A | Additional proxy materials |
| Mar 26, 2025DEF 14A | Proxy statement |
| Feb 13, 202510-K | Annual report, FY2024 — revenue $20.10B (+3% y/y), net income $2.89B, EPS $3.51 |
| Jan 31, 20258-K | Earnings release — EPS $0.91 vs $0.89 est. (+2.3%); revenue $4.95B (−0% y/y) 4.6% |
| Jan 24, 20258-K/A | Results of operations; Other events |
2024 · 14 filings
| Filed | What it is |
|---|---|
| Oct 25, 202410-Q | Quarterly report, Q3 2024 — revenue $5.03B (+2% y/y), net income $737.0M, EPS $0.90 |
| Oct 25, 20248-K | Other events |
| Jul 26, 202410-Q | Quarterly report, Q2 2024 — revenue $5.06B (+5% y/y), net income $731.0M, EPS $0.89 |
| Jul 26, 20248-K | Earnings release — EPS $0.91 vs $0.87 est. (+4.6%); revenue $5.06B (+5% y/y) 3.0% |
| May 15, 20248-K | Shareholder vote results |
| Apr 26, 202410-Q | Quarterly report, Q1 2024 — revenue $5.07B (+6% y/y), net income $683.0M, EPS $0.83 |
| Apr 26, 20248-K | Earnings release — EPS $0.86 vs $0.82 est. (+4.9%); revenue $5.07B (+6% y/y) 1.9% |
| Apr 18, 2024DEFA14A | Additional proxy materials |
| Mar 27, 2024ARS | Annual report to shareholders |
| Mar 27, 2024DEFA14A | Additional proxy materials |
| Mar 27, 2024DEF 14A | Proxy statement |
| Feb 15, 20248-K | Directors or officers; compensation |
| Feb 15, 202410-K | Annual report, FY2023 — revenue $19.46B (+8% y/y), net income $2.30B, EPS $2.77 |
| Jan 26, 20248-K | Earnings release — EPS $0.87 vs $0.85 est. (+2.4%); revenue $4.95B (+7% y/y) 2.0% |
2023 · 18 filings — 10 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Oct 27, 202310-Q | Quarterly report, Q3 2023 — revenue $4.92B (+10% y/y), net income $708.0M, EPS $0.86 |
| Jul 28, 202310-Q | Quarterly report, Q2 2023 — revenue $4.82B (+8% y/y), net income $502.0M, EPS $0.60 |
| Apr 28, 202310-Q | Quarterly report, Q1 2023 — revenue $4.77B (+8% y/y), net income $372.0M, EPS $0.45 |
| Apr 20, 2023DEFA14A | Additional proxy materials |
| Mar 29, 2023ARS | Annual report to shareholders |
| Mar 29, 2023DEFA14A | Additional proxy materials |
| Mar 29, 2023DEF 14A | Proxy statement |
| Feb 16, 202310-K | Annual report, FY2022 — revenue $17.97B (+3% y/y), net income $1.78B, EPS $2.13 |
10 current reports (8-K) not listed; the year is on EDGAR.
2022 · 17 filings — 9 × 8-K, 3 × 10-Q, 3 × DEFA14A and 2 other forms
| Filed | What it is |
|---|---|
| Oct 28, 202210-Q | Quarterly report, Q3 2022 — revenue $4.46B (+1% y/y), net income $618.0M, EPS $0.74 |
| Jul 29, 202210-Q | Quarterly report, Q2 2022 — revenue $4.48B (+5% y/y), net income $603.0M, EPS $0.72 |
| Apr 29, 202210-Q | Quarterly report, Q1 2022 — revenue $4.40B (+1% y/y), net income $559.0M, EPS $0.66 |
| Apr 14, 2022DEFA14A | Additional proxy materials |
| Apr 11, 2022DEFA14A | Additional proxy materials |
| Mar 23, 2022DEFA14A | Additional proxy materials |
| Mar 23, 2022DEF 14A | Proxy statement |
| Feb 17, 202210-K | Annual report, FY2021 — revenue $17.42B (+6% y/y), net income $2.17B, EPS $2.55 |
9 current reports (8-K) not listed; the year is on EDGAR.
2021 · 19 filings — 11 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Oct 29, 202110-Q | Quarterly report, Q3 2021 — revenue $4.41B (+6% y/y), net income $634.0M, EPS $0.75 |
| Jul 30, 202110-Q | Quarterly report, Q2 2021 — revenue $4.26B (+9% y/y), net income $703.0M, EPS $0.83 |
| Apr 30, 202110-Q | Quarterly report, Q1 2021 — revenue $4.34B (+6% y/y), net income $681.0M, EPS $0.80 |
| Apr 15, 2021DEFA14A | Additional proxy materials |
| Mar 24, 2021DEFA14A | Additional proxy materials |
| Mar 24, 2021DEF 14A | Proxy statement |
| Feb 18, 202110-K | Annual report, FY2020 — revenue $16.47B (+5% y/y), net income $2.69B, EPS $3.14 |
12 current reports (8-K) not listed; the year is on EDGAR.
2020 · 15 filings — 8 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms
| Filed | What it is |
|---|---|
| Oct 30, 202010-Q | Quarterly report, Q3 2020 — revenue $4.15B (+6% y/y), net income $698.0M, EPS $0.81 |
| Jul 31, 202010-Q | Quarterly report, Q2 2020 — revenue $3.90B (+1% y/y), net income $635.0M, EPS $0.74 |
| May 1, 202010-Q | Quarterly report, Q1 2020 — revenue $4.10B (+5% y/y), net income $715.0M, EPS $0.83 |
| Apr 17, 2020DEFA14A | Additional proxy materials |
| Mar 25, 2020DEFA14A | Additional proxy materials |
| Mar 25, 2020DEF 14A | Proxy statement |
| Feb 21, 202010-K | Annual report, FY2019 — revenue $15.69B (+1% y/y), net income $2.37B, EPS $2.75 |
8 current reports (8-K) not listed; the year is on EDGAR.
2019 · 19 filings — 12 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms
| Filed | What it is |
|---|---|
| Nov 1, 201910-Q | Quarterly report, Q3 2019 — revenue $3.93B (+2% y/y), net income $578.0M, EPS $0.67 |
| Jul 26, 201910-Q | Quarterly report, Q2 2019 — revenue $3.87B (−1% y/y), net income $586.0M, EPS $0.68 |
| Apr 26, 201910-Q | Quarterly report, Q1 2019 — revenue $3.88B (−3% y/y), net income $560.0M, EPS $0.65 |
| Apr 18, 2019DEFA14A | Additional proxy materials |
| Mar 27, 2019DEFA14A | Additional proxy materials |
| Mar 27, 2019DEF 14A | Proxy statement |
| Feb 21, 201910-K | Annual report, FY2018 — revenue $15.54B (+1% y/y), net income $2.40B, EPS $2.75 |
12 current reports (8-K) not listed; the year is on EDGAR.
2018 · 20 filings — 12 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Oct 26, 201810-Q | Quarterly report, Q3 2018 — revenue $3.85B (−3% y/y), net income $523.0M, EPS $0.60 |
| Jul 27, 201810-Q | Quarterly report, Q2 2018 — revenue $3.89B (+2% y/y), net income $637.0M, EPS $0.73 |
| Apr 27, 201810-Q | Quarterly report, Q1 2018 — revenue $4.00B (+6% y/y), net income $634.0M, EPS $0.72 |
| Apr 20, 2018DEFA14A | Additional proxy materials |
| Mar 28, 2018DEFA14A | Additional proxy materials |
| Mar 28, 2018DEF 14A | Proxy statement |
| Feb 21, 201810-K/A | Annual report, amended |
| Feb 15, 201810-K | Annual report |
12 current reports (8-K) not listed; the year is on EDGAR.
2017 · 13 filings — 6 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms
| Filed | What it is |
|---|---|
| Oct 27, 201710-Q | Quarterly report, Q3 2017 — revenue $3.97B (+3% y/y), net income $607.0M, EPS $0.68 |
| Jul 21, 201710-Q | Quarterly report, Q2 2017 — revenue $3.83B (−0% y/y), net income $524.0M, EPS $0.59 |
| Apr 28, 201710-Q | Quarterly report, Q1 2017 — revenue $3.76B (+0% y/y), net income $570.0M, EPS $0.64 |
| Apr 21, 2017DEFA14A | Additional proxy materials |
| Mar 29, 2017DEFA14A | Additional proxy materials |
| Mar 29, 2017DEF 14A | Proxy statement |
| Feb 23, 201710-K | Annual report, FY2016 — revenue $15.20B (−5% y/y), net income $2.44B, EPS $2.72 |
6 current reports (8-K) not listed; the year is on EDGAR.
2016 · 18 filings — 10 × 8-K, 3 × 10-Q, 3 × DEFA14A and 2 other forms
Counted, not listed; the year is on EDGAR.
2015 · 15 filings — 7 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
Counted, not listed; the year is on EDGAR.
2014 · 17 filings — 9 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
Counted, not listed; the year is on EDGAR.
2013 · 16 filings — 8 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
Counted, not listed; the year is on EDGAR.
2012 · 15 filings — 6 × 8-K, 3 × 10-Q, 3 × DEFA14A and 3 other forms
Counted, not listed; the year is on EDGAR.
2011 · 18 filings — 8 × 8-K, 3 × 10-Q, 3 × DEFA14A and 4 other forms
Counted, not listed; the year is on EDGAR.
2010 · 20 filings — 10 × 8-K, 3 × 10-Q, 3 × DEFA14A and 4 other forms
Counted, not listed; the year is on EDGAR.
2009 · 13 filings — 5 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
Counted, not listed; the year is on EDGAR.
2008 · 18 filings — 7 × 8-K, 3 × 10-Q, 3 × DEFA14A and 5 other forms
Counted, not listed; the year is on EDGAR.
2007 · 18 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2006 · 16 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2005 · 22 filings — 16 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2004 · 16 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2003 · 11 filings — 4 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms
Counted, not listed; the year is on EDGAR.
2002 · 9 filings — 4 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2001 · 5 filings — 3 × 10-Q, 1 × 10-K405, 1 × DEF 14A
Counted, not listed; the year is on EDGAR.
2000 · 5 filings — 3 × 10-Q, 1 × 10-K405, 1 × DEF 14A
Counted, not listed; the year is on EDGAR.
1999 · 5 filings — 3 × 10-Q, 1 × 10-K405, 1 × DEF 14A
Counted, not listed; the year is on EDGAR.
1998 · 7 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K405 and 1 other form
Counted, not listed; the year is on EDGAR.
1997 · 8 filings — 3 × 10-Q, 1 × 10-K, 1 × 8-K and 3 other forms
Counted, not listed; the year is on EDGAR.
1996 · 7 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
1995 · 10 filings — 3 × 10-Q, 3 × 8-K, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
1994 · 6 filings — 3 × 10-Q, 1 × 10-K, 1 × 8-K and 1 other form
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 76 filings — 57 × 4, 11 × 144, 2 × 11-K and 5 other forms
| Filed | What it is |
|---|---|
| Oct 2, 20264 | Insider transaction (Form 4) |
| Oct 2, 20264 | Insider transaction (Form 4) |
| Oct 2, 20264 | Insider transaction (Form 4) |
| Sep 18, 20264 | Insider transaction (Form 4) |
| Sep 18, 20264 | Insider transaction (Form 4) |
| Sep 18, 20264 | Insider transaction (Form 4) |
| Sep 18, 20264 | Insider transaction (Form 4) |
| Sep 18, 20264 | Insider transaction (Form 4) |
| Sep 18, 20264 | Insider transaction (Form 4) |
| Sep 18, 20264 | Insider transaction (Form 4) |
| Sep 18, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Sep 15, 20264 | Insider transaction (Form 4) |
| Aug 26, 20264 | Insider transaction (Form 4) |
| Aug 24, 2026144 | Notice of proposed sale (Form 144) |
| Aug 7, 20264 | Insider transaction (Form 4) |
| Aug 6, 2026144 | Notice of proposed sale (Form 144) |
| Aug 6, 20264 | Insider transaction (Form 4) |
| Aug 5, 2026144 | Notice of proposed sale (Form 144) |
The newest 25 of 76 shown; the full year is on EDGAR.
2025 · 69 filings — 55 × 4, 4 × 424B2, 2 × 11-K and 6 other forms
| Filed | What it is |
|---|---|
| Dec 5, 20254 | Insider transaction (Form 4) |
| Dec 5, 20254 | Insider transaction (Form 4) |
| Dec 5, 20254 | Insider transaction (Form 4) |
| Dec 5, 20254 | Insider transaction (Form 4) |
| Dec 5, 20254 | Insider transaction (Form 4) |
| Dec 5, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 10, 2025CERT | NYSE CERTIFICATION |
| Nov 10, 20258-A12B | Exchange listing registration |
| Nov 5, 2025424B2 | Prospectus supplement |
| Nov 3, 2025FWP | Free writing prospectus |
| Nov 3, 2025424B2 | Prospectus supplement |
| Oct 3, 20254 | Insider transaction (Form 4) |
| Oct 3, 20254 | Insider transaction (Form 4) |
| Oct 3, 20254 | Insider transaction (Form 4) |
| Sep 16, 20254 | Insider transaction (Form 4) |
| Sep 16, 20254 | Insider transaction (Form 4) |
| Sep 16, 20254 | Insider transaction (Form 4) |
| Sep 16, 20254 | Insider transaction (Form 4) |
| Sep 16, 20254 | Insider transaction (Form 4) |
| Sep 16, 20254 | Insider transaction (Form 4) |
| Sep 16, 20254 | Insider transaction (Form 4) |
| Sep 16, 20254 | Insider transaction (Form 4) |
| Sep 12, 20254 | Insider transaction (Form 4) |
| Sep 12, 20254 | Insider transaction (Form 4) |
The newest 25 of 69 shown; the full year is on EDGAR.
2024 · 105 filings — 73 × 4, 23 × 144, 5 × SC 13G/A and 3 other forms
| Filed | What it is |
|---|---|
| Dec 5, 20244 | Insider transaction (Form 4) |
| Dec 5, 20244 | Insider transaction (Form 4) |
| Dec 5, 20244 | Insider transaction (Form 4) |
| Dec 5, 20244 | Insider transaction (Form 4) |
| Dec 5, 20244 | Insider transaction (Form 4) |
| Dec 5, 20244 | Insider transaction (Form 4) |
| Nov 27, 20244 | Insider transaction (Form 4) |
| Nov 26, 20244 | Insider transaction (Form 4) |
| Nov 22, 2024144 | Notice of proposed sale (Form 144) |
| Nov 12, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 7, 20244 | Insider transaction (Form 4) |
| Nov 5, 2024144 | Notice of proposed sale (Form 144) |
| Nov 5, 20244 | Insider transaction (Form 4) |
| Nov 5, 20244 | Insider transaction (Form 4) |
| Nov 4, 2024144 | Notice of proposed sale (Form 144) |
| Nov 1, 2024144 | Notice of proposed sale (Form 144) |
| Oct 22, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Oct 3, 20244 | Insider transaction (Form 4) |
| Oct 3, 20244 | Insider transaction (Form 4) |
| Oct 3, 20244 | Insider transaction (Form 4) |
| Oct 3, 20244 | Insider transaction (Form 4) |
| Sep 16, 20244 | Insider transaction (Form 4) |
| Sep 16, 20244 | Insider transaction (Form 4) |
| Sep 16, 20244 | Insider transaction (Form 4) |
| Sep 16, 20244 | Insider transaction (Form 4) |
The newest 25 of 105 shown; the full year is on EDGAR.
2023 · 104 filings — 76 × 4, 17 × 144, 3 × SC 13G/A and 6 other forms
Counted, not listed; the year is on EDGAR.
2022 · 69 filings — 58 × 4, 3 × SC 13G/A, 2 × 11-K and 5 other forms
Counted, not listed; the year is on EDGAR.
2021 · 87 filings — 74 × 4, 2 × 11-K, 2 × 424B2 and 8 other forms
Counted, not listed; the year is on EDGAR.
2020 · 102 filings — 91 × 4, 3 × 3, 2 × 11-K and 5 other forms
Counted, not listed; the year is on EDGAR.
2019 · 111 filings — 87 × 4, 4 × 3, 4 × 424B2 and 10 other forms
Counted, not listed; the year is on EDGAR.
2018 · 106 filings — 97 × 4, 2 × 11-K, 2 × 5 and 4 other forms
Counted, not listed; the year is on EDGAR.
2017 · 129 filings — 102 × 4, 6 × 5, 3 × 424B2 and 11 other forms
Counted, not listed; the year is on EDGAR.
2016 · 122 filings — 104 × 4, 5 × 5, 3 × UPLOAD and 7 other forms
Counted, not listed; the year is on EDGAR.
2015 · 135 filings — 112 × 4, 3 × 3, 3 × 424B2 and 10 other forms
Counted, not listed; the year is on EDGAR.
2014 · 171 filings — 149 × 4, 5 × 424B2, 4 × 5 and 8 other forms
Counted, not listed; the year is on EDGAR.
2013 · 242 filings — 208 × 4, 7 × CORRESP, 5 × 424B2 and 8 other forms
Counted, not listed; the year is on EDGAR.
2012 · 222 filings — 202 × 4, 4 × 3, 3 × 424B2 and 7 other forms
Counted, not listed; the year is on EDGAR.
2011 · 199 filings — 167 × 4, 6 × 424B2, 5 × FWP and 9 other forms
Counted, not listed; the year is on EDGAR.
2010 · 262 filings — 236 × 4, 5 × 424B2, 4 × 3 and 9 other forms
Counted, not listed; the year is on EDGAR.
2009 · 218 filings — 201 × 4, 7 × 5, 2 × 3 and 7 other forms
Counted, not listed; the year is on EDGAR.
2008 · 197 filings — 173 × 4, 6 × 3, 4 × 424B2 and 8 other forms
Counted, not listed; the year is on EDGAR.
2007 · 167 filings — 147 × 4, 4 × UPLOAD, 3 × 5 and 10 other forms
Counted, not listed; the year is on EDGAR.
2006 · 139 filings — 122 × 4, 4 × 5, 2 × 3 and 7 other forms
Counted, not listed; the year is on EDGAR.
2005 · 154 filings — 135 × 4, 4 × 3, 3 × 424B3 and 9 other forms
Counted, not listed; the year is on EDGAR.
2004 · 158 filings — 149 × 4, 3 × 5, 2 × SC 13G/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2003 · 56 filings — 43 × 4, 4 × 424B3, 3 × 3 and 5 other forms
Counted, not listed; the year is on EDGAR.
2002 · 10 filings — 6 × 424B3, 1 × 11-K, 1 × NO ACT and 2 other forms
Counted, not listed; the year is on EDGAR.
2001 · 9 filings — 5 × 424B3, 1 × 424B2, 1 × S-3 and 2 other forms
Counted, not listed; the year is on EDGAR.
2000 · 10 filings — 6 × 424B3, 1 × 424B2, 1 × 424B5 and 2 other forms
Counted, not listed; the year is on EDGAR.
1999 · 6 filings — 4 × 424B3, 1 × S-8, 1 × SC 13G/A
Counted, not listed; the year is on EDGAR.
1998 · 24 filings — 21 × 424B3, 1 × 8-A12B, 1 × S-8 and 1 other form
Counted, not listed; the year is on EDGAR.
1997 · 3 filings — 2 × S-8, 1 × SC 13G/A
Counted, not listed; the year is on EDGAR.
1996 · 5 filings — 3 × 424B3, 1 × 424B5, 1 × SC 13G/A
Counted, not listed; the year is on EDGAR.
1995 · 8 filings — 2 × 424B5, 2 × S-8, 1 × 424B3 and 3 other forms
Counted, not listed; the year is on EDGAR.
1994 · 4 filings — 1 × 424B2, 1 × 424B3, 1 × S-3 and 1 other form
Counted, not listed; the year is on EDGAR.
About this data#
Colgate-Palmolive Company (CL) has 3,941 filings on EDGAR going back to 1994: 34 annual reports, 99 quarterly reports and 226 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 23, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Jul 31, 2026, furnished a press release headed “Colgate Announces 2nd Quarter 2026 Results”. Over the last 13 months insiders sold $57.0M in 14 sales and bought nothing on the open market; 103 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Colgate-Palmolive Company, read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read CL's latest 10-K?
- CL's latest annual report, a 10-K, was filed on Feb 23, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did CL last file an 8-K?
- On Jul 31, 2026 it furnished a press release headed “Colgate Announces 2nd Quarter 2026 Results”. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Jul 31, 2026.
- Are CL insiders buying or selling?
- Over the last 13 months insiders sold $57.0M in 14 sales and bought nothing on the open market; 103 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Tsourapas Panagiotis (COO, CD, EMEA, APac, Skin) sold 10,000 shares on Aug 24, 2026 for $920K. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has CL made?
- 3,941 filings are on EDGAR under the registrant records that have been Colgate-Palmolive Company, going back to 1994; 3,101 of them are insider ownership forms (Forms 3, 4, 5 and 144).
